TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15590859

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-coated sleeve
Number of subjects: 42

Group type: COMPARATOR
Intervention: Porous-coated sleeve
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both implant types
Number of subjects: 42
Study: 12577370

Group type: EXPERIMENTAL
Intervention: Yizhidan (YZD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ritalin
Number of subjects: 0
Study: 11565519

Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg daily
Number of subjects: 590

Group type: EXPERIMENTAL
Intervention: Irbesartan 150 mg daily
Number of subjects: 590

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 590

Group type: EXPERIMENTAL
Intervention: Combined irbesartan groups
Number of subjects: 590
Study: 9027668

Group type: EXPERIMENTAL
Intervention: Antibacterials used in Hospital 1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antibacterials used in Hospital 2
Number of subjects: 0
Study: 8393509

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Azathioprine and Methotrexate
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combination therapy of oral azathioprine and methotrexate and high-dose intravenous methotrexate with leucovorin rescue
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Presence of active inflammation at entry into the prospective therapeutic protocol
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Complete laboratory response with normalization of creatine kinase and other muscle-associated enzymes
Number of subjects: 25
Study: 3034018

Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg once daily
Number of subjects: 76

Group type: COMPARATOR
Intervention: Captopril 50 mg twice daily
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (concomitant treatment for nonresponders)
Number of subjects: 76
Study: 28633534

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (n=24)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (n=25)
Number of subjects: 70
Study: 27147783

Group type: COMPARATOR
Intervention: Povidone iodine (PI) only
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Alkosol (96% ethanol, isopropanol‐30g and ortophenilphenol‐0.1g) and povidone iodide
Number of subjects: 100
Study: 23812851

Group type: EXPERIMENTAL
Intervention: Mini-open rotator cuff repair (Group I)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff repair (Group II)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Comparison between Group I and Group II
Number of subjects: 125
Study: 22790892

Group type: EXPERIMENTAL
Intervention: Endoscopic carpal tunnel release (ECTR)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Open carpal tunnel release (OCTR)
Number of subjects: 79
Study: 21254673

Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Pump of vein odynolysis (Group B)
Number of subjects: 80
Study: 18957490

Group type: EXPERIMENTAL
Intervention: 5-day participatory-style educational program
Number of subjects: 304

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 304
Study: 15662290

Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ) 20 mg t.i.d.
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo (Pbo) t.i.d.
Number of subjects: 166
Study: 12891544

Group type: EXPERIMENTAL
Intervention: Gastric electrical stimulation ON
Number of subjects: 33
Study: 10233186

Group type: EXPERIMENTAL
Intervention: bosentan 700 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: misoprostol 400 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study: 8904256

Group type: EXPERIMENTAL
Intervention: High-dose vecuronium (0.3 mg kg‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pancuronium (0.1 mg kg‐1)
Number of subjects: 0
Study: 1687320

Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29555790

Group type: EXPERIMENTAL
Intervention: Chlorothiazide 500 mg
Number of subjects: 3244

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3244
Study: 29469431

Group type: EXPERIMENTAL
Intervention: Clinical nursing path integrated with holistic nursing
Number of subjects: 226

Group type: COMPARATOR
Intervention: Holistic nursing (control group)
Number of subjects: 226
Study: 23662595

Group type: EXPERIMENTAL
Intervention: Web-based Triple P 'Positive Parenting Programme'
Number of subjects: 0
Study: 22046993

Group type: EXPERIMENTAL
Intervention: Functional group counseling (24-week intervention)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Comparison Group I (51 low-achieving students)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Comparison Group II (43 moderate or high academic achieving students)
Number of subjects: 43
Study: 19663893

Group type: EXPERIMENTAL
Intervention: Steroid withdrawal
Number of subjects: 132

Group type: COMPARATOR
Intervention: Continued low-dose steroids
Number of subjects: 132

Group type: COMPARATOR
Intervention: Steroid withdrawal and continued low-dose steroids
Number of subjects: 132
Study: 18445841

Group type: EXPERIMENTAL
Intervention: [(177)Lu-DOTA(0),Tyr(3)]octreotate
Number of subjects: 504
Study: 17008577

Group type: EXPERIMENTAL
Intervention: Staged care intervention participants received computerized motivational feedback at baseline and at 3, 6, and 12 months, and were offered a 6-session psychological counseling and pharmacological cessation treatment program.
Number of subjects: 322

Group type: COMPARATOR
Intervention: Brief contact control participants received a self-help guide and referral list of local smoking-treatment providers.
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Staged care intervention
Number of subjects: 322
Study: 14574348

Group type: EXPERIMENTAL
Intervention: almond‐LCD (84 g/day of almonds, 39% total fat, 25% MUFA, 32% carbohydrate)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: almond‐LCD (84 g/day of almonds)
Number of subjects: 65

Group type: COMPARATOR
Intervention: CHO‐LCD (self‐selected complex carbohydrates, 18% total fat, 5% MUFA, 53% carbohydrate)
Number of subjects: 65

Group type: COMPARATOR
Intervention: CHO‐LCD (self‐selected complex carbohydrates)
Number of subjects: 65
Study: 10751249

Group type: EXPERIMENTAL
Intervention: AG284
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 8703461

Group type: EXPERIMENTAL
Intervention: Trendelenburg posture (head-down, 15 degrees from horizontal)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Supine posture
Number of subjects: 15

Group type: COMPARATOR
Intervention: Head-up posture (10 degrees from horizontal)
Number of subjects: 15
Study: 1301232

Group type: EXPERIMENTAL
Intervention: 80 mg propranolol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cardiac volume load
Number of subjects: 15
Study: 3859636

Group type: EXPERIMENTAL
Intervention: Active dentifrice containing 0.8% sodium monofluorophosphate and 1.3% formalin
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control dentifrice (lacking active ingredients)
Number of subjects: 67
Study: 31382210

Group type: EXPERIMENTAL
Intervention: TENS (pulse of 200 μs, frequency at 10 Hz, in motor threshold) for 20 min followed by 30 min of vocal therapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo TENS for 20 min followed by 30 min of vocal therapy
Number of subjects: 27
Study: 29073768

Group type: EXPERIMENTAL
Intervention: Educational intervention video (n = 225)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Control group (sudden infant death syndrome video, n = 202)
Number of subjects: 427
Study: 26730890

Group type: EXPERIMENTAL
Intervention: Invasive urodynamic testing
Number of subjects: 29

Group type: COMPARATOR
Intervention: Basic clinical assessment with non-invasive tests
Number of subjects: 29
Study: 22685122

Group type: EXPERIMENTAL
Intervention: Hydration condition (Hyd)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dehydration condition (Dehyd)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (Cont)
Number of subjects: 0
Study: 22646630

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy followed by surgery
Number of subjects: 368

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 368
Study: 20202675

Group type: EXPERIMENTAL
Intervention: Silorane System Adhesive (2-step self-etch adhesive)
Number of subjects: 0
Study: 18818443

Group type: EXPERIMENTAL
Intervention: 5 mg of donepezil (Aricept) daily for 6 weeks, increased to 10 mg daily for another 6 weeks, followed by cognitive training for 2 weeks and maintained for 1 year
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo daily for 6 weeks, followed by cognitive training for 2 weeks and maintained for 1 year
Number of subjects: 168
Study: 16135900

Group type: EXPERIMENTAL
Intervention: CPG 7909 + Engerix-B
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline + Engerix-B (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CPG 7909 alone
Number of subjects: 0
Study: 11994052

Group type: EXPERIMENTAL
Intervention: Metformin (1500 mg day-1)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Clomiphene (50-100 mg for 5 days) with Metformin
Number of subjects: 26

Group type: COMPARATOR
Intervention: Clomiphene (50-100 mg for 5 days) with Placebo
Number of subjects: 26
Study: 10102252

Group type: EXPERIMENTAL
Intervention: Weight loss after 3 weeks
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Weight loss between week 3 and week 20
Number of subjects: 54

Group type: COMPARATOR
Intervention: Restarting sulfonylureas after week 3
Number of subjects: 54
Study: 7772427

Group type: EXPERIMENTAL
Intervention: Tranexamic acid 15 mg kg‐1
Number of subjects: 29
Study: 2268019

Group type: EXPERIMENTAL
Intervention: Unlimited clear fluid ingestion up to two hours before surgery
Number of subjects: 228

Group type: COMPARATOR
Intervention: Unlimited clear fluid ingestion up to two and a half hours before surgery
Number of subjects: 228
Study: 442002

Group type: EXPERIMENTAL
Intervention: Intraderma injection of a suspension of irradiated autologous tumour-cells mixed with intradermal BCG
Number of subjects: 52

Group type: COMPARATOR
Intervention: Non-autograft group
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study: 31272931

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10000
Study: 28097266

Group type: EXPERIMENTAL
Intervention: Supine posture during first filling cystometry
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Supine posture
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Second filling cystometry
Number of subjects: 71

Group type: COMPARATOR
Intervention: Erect posture
Number of subjects: 71
Study: 25340318

Group type: EXPERIMENTAL
Intervention: 36IPT
Number of subjects: 1006

Group type: EXPERIMENTAL
Intervention: 36IPT with ART
Number of subjects: 1006
Study: 23688859

Group type: EXPERIMENTAL
Intervention: Disclaimer
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Warning
Number of subjects: 342

Group type: COMPARATOR
Intervention: Model control
Number of subjects: 342

Group type: COMPARATOR
Intervention: Car control
Number of subjects: 342
Study: 21860157

Group type: EXPERIMENTAL
Intervention: Topical 5% permethrin (group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oral ivermectin (200 μg/kg/dose) in a single dose (group B)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oral ivermectin (200 μg/kg/dose) in a double dose regimen (group C)
Number of subjects: 120
Study: 19462326

Group type: EXPERIMENTAL
Intervention: Flavor-enhanced tomato soup (1,200 mg/l MSG + 3 g/l celery powder)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Non-enhanced soup
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Flavor-enhanced tomato soup
Number of subjects: 120
Study: 16946093

Group type: EXPERIMENTAL
Intervention: Inhalation of 100 microg LPS
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 16
Study: 12939535

Group type: EXPERIMENTAL
Intervention: Volleyball players
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Basketball players
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison between volleyball and basketball players
Number of subjects: 23
Study: 10924300

Group type: EXPERIMENTAL
Intervention: Atrial pacing at 500 ms
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Atrial pacing at 300 ms
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intravenous sotalol (1.5 mg. kg(‐1))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Repeated defibrillation
Number of subjects: 12
Study: 8644832

Group type: EXPERIMENTAL
Intervention: Activity-based therapy regimen (30 min each day)
Number of subjects: 3
Study: 1899984

Group type: COMPARATOR
Intervention: Mouth‐to-mouth
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Mouth‐to-mask
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Bag-valve-(soft) mask
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Bag-valve-(rigid) mask
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Tube-valve-mask
Number of subjects: 17
Study: 6733063

Group type: EXPERIMENTAL
Intervention: Graduated compression stockings worn by 104 patients
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group (92 patients not wearing stockings)
Number of subjects: 196
Study: 31213572

Group type: EXPERIMENTAL
Intervention: Individual inhalation training (study group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham procedure (control group)
Number of subjects: 100
Study: 30443533

Group type: EXPERIMENTAL
Intervention: Motor Control Exercise (MCE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Patient Education (PE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MCE plus PE
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (PE)
Number of subjects: 30
Study: 27121444

Group type: EXPERIMENTAL
Intervention: Benazepril or Imidapril for 6 weeks
Number of subjects: 497
Study: 24201696

Group type: EXPERIMENTAL
Intervention: 4 mg perindopril daily for 20 weeks
Number of subjects: 170

Group type: COMPARATOR
Intervention: Matching placebo daily for 20 weeks
Number of subjects: 170
Study: 22776627

Group type: EXPERIMENTAL
Intervention: Helmet therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No helmet therapy
Number of subjects: 0
Study: 20235838

Group type: EXPERIMENTAL
Intervention: ART with 4 weeks of cyclosporine
Number of subjects: 54

Group type: COMPARATOR
Intervention: ART alone
Number of subjects: 54
Study: 17701926

Group type: EXPERIMENTAL
Intervention: Blind access (group 1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard access using fluoroscopy (group 2)
Number of subjects: 100
Study: 15791438

Group type: EXPERIMENTAL
Intervention: Manual ROI definition (SUV[MAN])
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed dimensions ROI definition (SUV15 mm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed dimensions ROI definition (SUV50)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed dimensions ROI definition (SUV75)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maximum pixel value ROI definition (SUVmax)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ordered Subsets Expectation Maximisation (OSEM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Filtered Back-Projection (FBP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manual and 50% threshold ROIs for metabolic volumes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 75% threshold and maximum pixel ROIs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold-based and fixed dimension methods
Number of subjects: 0
Study: 14717251

Group type: EXPERIMENTAL
Intervention: Social contextual approach
Number of subjects: 1118

Group type: EXPERIMENTAL
Intervention: Lack of nurturant and involved parenting
Number of subjects: 1118

Group type: EXPERIMENTAL
Intervention: Child antisocial behavior and deviant peer affiliations at Time 2
Number of subjects: 1118
Study: 10422930

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided cannulation
Number of subjects: 95

Group type: COMPARATOR
Intervention: Landmarks method
Number of subjects: 95
Study: 7593436

Group type: EXPERIMENTAL
Intervention: Sandostatin-LAR (20, 30, or 40 mg) administered via intramuscular injections at 28- or 42-day intervals
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sandostatin-LAR
Number of subjects: 8
Study: 2294528

Group type: EXPERIMENTAL
Intervention: Helium-neon laser stimulation (Experimental Group, n = 41)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham stimulation (Control Group, n = 39)
Number of subjects: 80
Study: 568935

Group type: EXPERIMENTAL
Intervention: Amaranthus spp. leaves cooked without draining water
Number of subjects: 6

Group type: COMPARATOR
Intervention: Amaranthus spp. leaves cooked with water drained
Number of subjects: 6
Study: 31986357

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Celecoxib and Placebo
Number of subjects: 47
Study: 31474649

Group type: EXPERIMENTAL
Intervention: Extragenic mutations bypassed the essentiality of 20 genes (22%); 15 of which have not been previously reported.
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Half of the bypass-suppressible genes were involved in mitochondria function; multiple genes regulating RNA processing were identified.
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 18 suppressible genes were conserved in the budding yeast Saccharomyces cerevisiae; 13 of them were non-essential in that species.
Number of subjects: 92
Study: 26150412

Group type: EXPERIMENTAL
Intervention: SCAMP (30% more parenteral nutrition amino acids)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control parenteral nutrition regimen
Number of subjects: 150

Group type: COMPARATOR
Intervention: SCAMP and Control
Number of subjects: 150
Study: 26404684

Group type: EXPERIMENTAL
Intervention: 3D laparoscopic and thoracoscopic esophagectomy
Number of subjects: 154

Group type: COMPARATOR
Intervention: 2D laparoscopic and thoracoscopic esophagectomy
Number of subjects: 154
Study: 22410962

Group type: EXPERIMENTAL
Intervention: High carbohydrate/high glycemic index (HC/HGI) diet
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: High carbohydrate/low glycemic index (HC/LGI) diet
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: High MUFA/high glycemic index (HM/HGI) diet
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: High MUFA/low glycemic index (HM/LGI) diet
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: High saturated fat (HS) diet
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: High fat diets (HM/HGI and HM/LGI)
Number of subjects: 88
Study: 21892112

Group type: EXPERIMENTAL
Intervention: Overnight wear of hydrogel and silicone hydrogel contact lenses in inexperienced and experienced wearers.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Overnight wear of contact lenses (CL).
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: NITBUT and comfort scores after CL insertion.
Number of subjects: 60
Study: 19651163

Group type: EXPERIMENTAL
Intervention: PYY3-36
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: PYY1-36
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 8
Study: 17572382

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Cognitive-behavioral group therapy (CBGT)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both interventions (MBSR and CBGT)
Number of subjects: 53
Study: 14996873

Group type: EXPERIMENTAL
Intervention: Hohmann procedure (distal osteotomy of the first metatarsal)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Lapidus procedure (arthrodesis of the first tarsometatarsal joint combined with soft-tissue procedure)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Both procedures (Hohmann and Lapidus)
Number of subjects: 101
Study: 11899783

Group type: EXPERIMENTAL
Intervention: Vinorelbine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vinorelbine in combination with trastuzumab and newer molecular targeting agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vinorelbine in doublets or triplets with drugs other than anthracyclines and taxanes
Number of subjects: 0
Study: 9272782

Group type: EXPERIMENTAL
Intervention: Morphine test
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Thiamylal test
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Ketamine test
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Chronic motor cortex stimulation therapy
Number of subjects: 39
Study: 7881144

Group type: EXPERIMENTAL
Intervention: 20 mL of bupivacaine during both S1 and S2 (Group C)
Number of subjects: 42

Group type: COMPARATOR
Intervention: 20 mL of saline during S1 and S2 (Group A)
Number of subjects: 42

Group type: COMPARATOR
Intervention: 20 mL of saline during S1 and 20 mL of bupivacaine during S2 (Group B)
Number of subjects: 42
Study: 2816636

Group type: EXPERIMENTAL
Intervention: Omnipaque 300 (nonionic, iohexol)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hypaque 60 (ionic, diatrizoate meglumine)
Number of subjects: 40
Study: 776464

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 0
Study: 31353275

Group type: EXPERIMENTAL
Intervention: Intervention group with CT-DM framework
Number of subjects: 431

Group type: COMPARATOR
Intervention: Control group without CT-DM framework
Number of subjects: 431
Study: 31443731

Group type: EXPERIMENTAL
Intervention: Extended lymphadenectomy
Number of subjects: 734

Group type: COMPARATOR
Intervention: Regional lymphadenectomy
Number of subjects: 734
Study: 28219132

Group type: EXPERIMENTAL
Intervention: Artery approach method
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional method (Control)
Number of subjects: 60
Study: 26068297

Group type: EXPERIMENTAL
Intervention: Intermittent PTH administration (iPTH)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Chronic PTH hypersecretion in primary hyperparathyroidism (PHP)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Surgical restoration of normal parathyroid function
Number of subjects: 82
Study: 23587982

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 25 mg/day (initial dose), titrated to a maximum of 100 mg/day based on clinical response
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine (various doses)
Number of subjects: 304